GBM fundamentals
INOVIO PHARMACEUTI revenue breakdown overview
INOVIO PHARMACEUTI revenue for the last year amounted to 197.77 k CHF, the most of which — 197.77 k CHF — came from its highest performing source at the moment, DNA Medicines, the year earlier bringing 700.50 k CHF. The greatest contribution to the revenue figure was made by United States — last year it brought INOVIO PHARMACEUTI 197.77 k CHF, and the year before that — 700.50 k CHF.
By source
By country